| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(09)70132-X |
| P698 | PubMed publication ID | 19555901 |
| P2093 | author name string | Christoph M Tang | |
| Rachel M Exley | |||
| Helena Lo | |||
| P2860 | cites work | Longitudinal study of asymptomatic meningococcal carriage in two Belgian populations of schoolchildren | Q71798023 |
| Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model | Q72682674 | ||
| Effect of the (alpha 2-->8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells | Q72940983 | ||
| Association of familial deficiency of mannose-binding lectin and meningococcal disease | Q73048684 | ||
| Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine | Q73700042 | ||
| Vaccine prevention of meningococcal disease: making slow progress | Q79327290 | ||
| Metabolism of nitric oxide by Neisseria meningitidis modifies release of NO-regulated cytokines and chemokines by human macrophages | Q80420560 | ||
| Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages | Q81072320 | ||
| Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease | Q83222896 | ||
| Functional significance of factor H binding to Neisseria meningitidis | Q83918204 | ||
| Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58 | Q22065549 | ||
| Complement factor H polymorphism in age-related macular degeneration | Q24553334 | ||
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| How neutrophils kill microbes | Q24672245 | ||
| The Neisseria meningitidis capsule is important for intracellular survival in human cells | Q24684877 | ||
| AP endonuclease paralogues with distinct activities in DNA repair and bacterial pathogenesis | Q27643887 | ||
| Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates | Q27653843 | ||
| Complement. First of two parts | Q28210663 | ||
| Complement factor H variant increases the risk of age-related macular degeneration | Q28239239 | ||
| Neisseria meningitidis: an overview of the carriage state | Q28277386 | ||
| Antimicrobial reactive oxygen and nitrogen species: concepts and controversies | Q28283086 | ||
| MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) IN MENINGOCOCCAL SEPTIC SHOCK AND EXPERIMENTAL HUMAN ENDOTOXEMIA | Q64132774 | ||
| Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein | Q64449501 | ||
| Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway | Q68322753 | ||
| Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease | Q71538870 | ||
| Occurrence of alpha 2-8 linked polysialosyl units in a neural cell adhesion molecule | Q71725772 | ||
| The NADPH oxidase and chronic granulomatous disease | Q28289081 | ||
| Complement factor H polymorphism and age-related macular degeneration | Q29614931 | ||
| Cationic antimicrobial peptide resistance in Neisseria meningitidis | Q30857151 | ||
| Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis | Q30891451 | ||
| Neutrophil granules: a library of innate immunity proteins | Q33290704 | ||
| Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. | Q33378236 | ||
| Factor H family proteins and human diseases | Q33380214 | ||
| The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum | Q33769638 | ||
| Update on meningococcal disease with emphasis on pathogenesis and clinical management | Q33812435 | ||
| The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. | Q33852676 | ||
| The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis | Q33879680 | ||
| Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. | Q33892877 | ||
| Cytokine-mediated regulation of antimicrobial proteins | Q33983999 | ||
| Epidemic meningitis, meningococcaemia, and Neisseria meningitidis | Q34644525 | ||
| Global adjustment of microbial physiology during free radical stress | Q34695153 | ||
| Reverse vaccinology: a genome-based approach for vaccine development | Q35040848 | ||
| Iron transport systems in Neisseria meningitidis | Q35684980 | ||
| Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? | Q35741515 | ||
| PorA variable regions of Neisseria meningitidis | Q35880198 | ||
| Complement: central to innate immunity and bridging to adaptive responses. | Q36064092 | ||
| Meningococcal surrogates of protection--serum bactericidal antibody activity | Q36065385 | ||
| A universal vaccine for serogroup B meningococcus | Q36101910 | ||
| Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis | Q36145701 | ||
| Membrane complement regulatory proteins | Q36336220 | ||
| Meningococcal genome dynamics. | Q36343551 | ||
| Available carbon source influences the resistance of Neisseria meningitidis against complement | Q36402993 | ||
| Complement and properidin deficiencies in meningococcal disease | Q36411073 | ||
| The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance | Q36470692 | ||
| Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak | Q36526303 | ||
| Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation | Q36545300 | ||
| A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies | Q36699790 | ||
| Cathelicidins and functional analogues as antisepsis molecules. | Q36897327 | ||
| The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. | Q36902238 | ||
| Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria | Q36932099 | ||
| Alternative mechanisms of action of cationic antimicrobial peptides on bacteria | Q37014658 | ||
| The role of epithelial beta-defensins and cathelicidins in host defense of the lung | Q37030668 | ||
| 2. Dendritic cells as regulators of immunity and tolerance | Q37074348 | ||
| Vaccine potential of the Neisseria meningitidis 2086 lipoprotein | Q37115883 | ||
| Antimicrobial peptides in innate immune responses. | Q37177017 | ||
| The role of neutrophils and monocytes in innate immunity | Q37177031 | ||
| Immune deficiency disorders involving neutrophils | Q37255649 | ||
| Lactoferrin: structure, function and applications | Q37289535 | ||
| Identification of 2 hypothetical genes involved in Neisseria meningitidis cathelicidin resistance. | Q38291200 | ||
| Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C. | Q38297705 | ||
| Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis | Q38326601 | ||
| Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci | Q38341389 | ||
| Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis | Q38342684 | ||
| Multiple mechanisms of phase variation of PorA in Neisseria meningitidis | Q39517149 | ||
| Interaction of Neisseria meningitidis with human dendritic cells | Q39529533 | ||
| Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells | Q39654947 | ||
| Nitric oxide metabolism in Neisseria meningitidis. | Q39679148 | ||
| Bacterial [Cu,Zn]-cofactored superoxide dismutase protects opsonized, encapsulated Neisseria meningitidis from phagocytosis by human monocytes/macrophages | Q39730098 | ||
| Recognition and control of neisserial infection by antibody and complement. | Q40455856 | ||
| The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia | Q40781106 | ||
| Complement deficiency states and meningococcal disease | Q40804745 | ||
| Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. | Q40825138 | ||
| Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease | Q41039806 | ||
| Bacterial transferrin and lactoferrin receptors | Q41051437 | ||
| The Effect of Chemoprophylactic Use of Rifampin and Minocycline on Rates of Carriage of Neisseria meningitidis in Army Recruits in Finland | Q41378539 | ||
| Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. | Q41825787 | ||
| Genetic interactions of DNA repair pathways in the pathogen Neisseria meningitidis | Q42412497 | ||
| Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa | Q42754647 | ||
| Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism | Q43185362 | ||
| Many carried meningococci lack the genes required for capsule synthesis and transport | Q43450474 | ||
| The differential response of human dendritic cells to live and killed Neisseria meningitidis | Q44192675 | ||
| Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells | Q44634205 | ||
| Optimization of virulence functions through glucosylation of Shigella LPS. | Q45282739 | ||
| Cationic polypeptides are required for antibacterial activity of human airway fluid. | Q45946168 | ||
| Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva | Q46204499 | ||
| IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans | Q46970232 | ||
| Defenses against oxidative stress in Neisseria gonorrhoeae and Neisseria meningitidis: distinctive systems for different lifestyles | Q47348879 | ||
| The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. | Q47904521 | ||
| Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. | Q48084641 | ||
| An anti-infective peptide that selectively modulates the innate immune response | Q50072960 | ||
| Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. | Q51824053 | ||
| Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. | Q51934437 | ||
| Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. | Q52934669 | ||
| Naturally occurring insertional inactivation of theporAgene ofNeisseria meningitidisby integration of IS1301 | Q63371254 | ||
| Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis | Q63728070 | ||
| P433 | issue | 7 | |
| P921 | main subject | vaccine | Q134808 |
| Neisseria meningitidis | Q154625 | ||
| P304 | page(s) | 418-427 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development | |
| P478 | volume | 9 |
| Q35202321 | An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei |
| Q47170219 | An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate |
| Q36725495 | Antigenic Variation in Bacterial Pathogens |
| Q39852648 | Approach to the Discovery, Development, and Evaluation of a Novel Neisseria meningitidis Serogroup B Vaccine |
| Q38011316 | Can we, should we, eradicate the meningococcus? |
| Q36668135 | Catabolism of N-acetylneuraminic acid, a fitness function of the food-borne lactic acid bacterium Lactobacillus sakei, involves two newly characterized proteins |
| Q39667409 | Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence |
| Q35887617 | Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country. |
| Q34075114 | Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages |
| Q27025703 | Designing vaccines for the twenty-first century society |
| Q34987045 | Domain exchange at the 3' end of the gene encoding the fratricide meningococcal two-partner secretion protein A. |
| Q41857413 | Draft genome sequences of two Neisseria meningitidis serogroup C clinical isolates |
| Q34484616 | Effect of Factor H-Binding Protein Sequence Variation on Factor H Binding and Survival ofNeisseria meningitidisin Human Blood |
| Q38058959 | Effect of vaccines on bacterial meningitis worldwide |
| Q41779897 | Fatal meningococcemia |
| Q86030304 | Fostering further successes in vaccinology |
| Q35453441 | From genes to vaccine: A breakthrough in the prevention of meningococcal group B disease |
| Q37111813 | Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells |
| Q34168814 | Genome sequence of Neisseria meningitidis serogroup B strain H44/76. |
| Q42840667 | Host defense pathways: role of redundancy and compensation in infectious disease phenotypes |
| Q26782340 | How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines |
| Q24288726 | Investigating the role of mitochondrial haplogroups in genetic predisposition to meningococcal disease |
| Q37037743 | Meningococcal Vaccine: Which, When and for Whom? |
| Q37878375 | Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence |
| Q34460783 | Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis |
| Q35194824 | Meningococcal glycoconjugate vaccines. |
| Q34068118 | Metabolism and virulence in Neisseria meningitidis |
| Q92541765 | Molecular interactions between Neisseria meningitidis and its human host |
| Q51908452 | Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. |
| Q33734798 | Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans |
| Q37474854 | Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum |
| Q36888510 | Neisseria meningitidis Polynucleotide Phosphorylase Affects Aggregation, Adhesion, and Virulence |
| Q38550405 | Neisseria meningitidis infection: who, when and where? |
| Q46269530 | Peripheral blood vessels are a niche for blood-borne meningococci. |
| Q34690369 | Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways |
| Q34499619 | Prevalence and clinical course in invasive infections with meningococcal endotoxin variants |
| Q35191828 | Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant |
| Q26995760 | Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease |
| Q27013956 | Safety assessment of adjuvanted vaccines: Methodological considerations |
| Q40287703 | Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial |
| Q58806131 | Spontaneous point mutations in the capsule synthesis locus leading to structural and functional changes of the capsule in serogroup A meningococcal populations |
| Q27715823 | Structure and mechanism of a molecular rheostat, an RNA thermometer that modulates immune evasion by Neisseria meningitidis |
| Q38737223 | The Hfq regulon of Neisseria meningitidis. |
| Q35989852 | The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens |
| Q36112670 | Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame |
| Q47108237 | Three tandem promoters, together with IHF, regulate growth phase dependent expression of the Escherichia coli kps capsule gene cluster. |
| Q33903848 | Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival |
| Q36340099 | Transcriptomic buffering of cryptic genetic variation contributes to meningococcal virulence |
| Q40092849 | Unraveling Neisseria meningitidis pathogenesis: from functional genomics to experimental models. |
Search more.